Attached files
| file | filename |
|---|---|
| EX-32.2 - EX-32.2 - LA JOLLA PHARMACEUTICAL CO | ljpc-ex322_6.htm |
| EX-32.1 - EX-32.1 - LA JOLLA PHARMACEUTICAL CO | ljpc-ex321_7.htm |
| EX-31.2 - EX-31.2 - LA JOLLA PHARMACEUTICAL CO | ljpc-ex312_8.htm |
| EX-31.1 - EX-31.1 - LA JOLLA PHARMACEUTICAL CO | ljpc-ex311_9.htm |
| EX-23.1 - EX-23.1 - LA JOLLA PHARMACEUTICAL CO | ljpc-ex231_655.htm |
| EX-10.13 - EX-10.13 - LA JOLLA PHARMACEUTICAL CO | ljpc-ex1013_883.htm |
| EX-10.11 - EX-10.11 - LA JOLLA PHARMACEUTICAL CO | ljpc-ex1011_1078.htm |
| EX-10.10 - EX-10.10 - LA JOLLA PHARMACEUTICAL CO | ljpc-ex1010_1367.htm |
| EX-10.9 - EX-10.9 - LA JOLLA PHARMACEUTICAL CO | ljpc-ex109_1079.htm |
| EX-10.8 - EX-10.8 - LA JOLLA PHARMACEUTICAL CO | ljpc-ex108_1080.htm |
| EX-10.7 - EX-10.7 - LA JOLLA PHARMACEUTICAL CO | ljpc-ex107_1081.htm |
| EX-10.6 - EX-10.6 - LA JOLLA PHARMACEUTICAL CO | ljpc-ex106_2214.htm |
| 10-K - 10-K - LA JOLLA PHARMACEUTICAL CO | ljpc-10k_20201231.htm |
Exhibit 21.1
Subsidiaries of La Jolla Pharmaceutical Company
|
|
||
|
|
|
|
|
Name of Subsidiary |
|
Jurisdiction |
|
La Jolla Pharma, LLC |
|
Delaware |
|
Tetraphase Pharmaceuticals, Inc. |
|
Delaware |
|
Tetraphase Pharma Securities, Inc. |
|
Massachusetts |
|
La Jolla Pharmaceutical Australia Pty Ltd |
|
Australia |
|
La Jolla Pharmaceutical I B.V. |
|
Netherlands |
|
La Jolla Pharmaceutical II B.V. |
|
Netherlands |
|
La Jolla Pharmaceutical III B.V. |
|
Netherlands |
|
Tetraphase Ireland Limited |
|
Republic of Ireland |
|
Tetraphase UK Limited |
|
United Kingdom |